Baxter reviews

It is a conservative company

Baxter has repeatedly misled its salesforce for over three years with empty promises of launching a competitive MCT (Mobile Cardiac Telemetry) device. Most recently, they announced yet another delay, pushing this so-called “launch” out by another year. Meanwhile, competitors have dominated this space for years, making it virtually impossible to gain meaningful market share. The market is oversaturated, and providers have no interest in a P-wave-centric device that offers no financial reimbursement. The CAM device itself is unreliable: it routinely falls off patients, often. Despite constant feedback, Baxter has failed to bring even a basic overlay sticker to market to address this issue, a minimal fix that has been requested for years. This speaks volumes about their lack of responsiveness and innovation. Internally, the situation is just as bleak. Quotas are set so unrealistically high that over 90% of the salesforce is consistently below plan. Only ~7% are at or above target at the moment. Micromanagement is rampant, morale is abysmal, and leadership appears more concerned with appearances than actual performance or support. If you’re considering this role, don’t. The division is structurally broken, strategically lost, and hemorrhaging credibility. It’s a professional dead end. Consider this your warning